Some of the names on the move ahead of the open.» Read More
Democratic Senator Carl Levin on Thursday said he plans to introduce legislation soon to prevent corporate inversions, an increasingly-popular transaction that involves U.S. companies reincorporating overseas to avoid U.S. taxes.
LONDON, May 8- The European Commission would probably block any attempt by the British government to intervene in Pfizer's proposed takeover of AstraZeneca as Brussels itself would rule on a deal of that size, competition lawyers say. AstraZeneca has rejected the $106 billion bid to create the world's largest pharmaceuticals business.
Some of the names on the move ahead of the open.
*AstraZeneca meeting shareholders to canvass views. LONDON, May 8- AstraZeneca shares gained 2 percent on Thursday on speculation that U.S. drugmaker Pfizer was about to return with a higher bid worth more than 53 pounds a share, traders said.
LONDON, May 8- AstraZeneca shares gained 2 percent in early trading on Thursday on speculation that U.S. drugmaker Pfizer was about to return with a higher bid worth more than 53 pounds a share, traders said.
British PM tells Pfizer wants more commitments for AstraZeneca deal. LONDON- Prime Minister David Cameron says Britain wants more commitments from Pfizer on its $106 billion takeover bid for British pharmaceutical company AstraZeneca.
*AstraZeneca forecasts show variables in drug modelling. LONDON, May 7- Ten-year sales forecasts from AstraZeneca- a central plank of its defence against a $106 billion bid approach from Pfizer- underscore how valuing drugs is an art as well as a science.
*Cameron hints Britain could intervene in takeover deal. LONDON, May 7- Prime Minister David Cameron demanded U.S. drugmaker Pfizer give stronger guarantees it will keep jobs and investment in Britain in order to secure his government's blessing for a takeover of AstraZeneca.
U.K. politicians from the right and the left are piling in to give their two cents on Pfizer's $106 billion bid for AstraZeneca.
LONDON, May 7- Britain should consider whether existing takeover laws giving ministers power to intervene in deals could be applied to U.S. drugmaker Pfizer's approach for London- listed AstraZeneca, Prime Minister David Cameron's spokesman said on Wednesday.
LONDON, May 7- Pfizer sought to allay fears that its proposed $106 billion takeover of AstraZeneca would deal a blow to drug research, saying the new company would bolster innovative science and speed the development of new treatments. AstraZeneca, Britain's second-largest drugs company, has rejected successive approaches from its larger American rival.
*UK could use public interest powers, Business Secretary says. *Lawmakers summon Pfizer, AstraZeneca bosses over takeover bid. LONDON, May 6- Britain could use its public interest powers to intervene in U.S. drugmaker Pfizer's $106- billion takeover bid for British pharmaceutical firm AstraZeneca, Business Secretary Vince Cable said on Tuesday.
May 6- Merck& Co Chief Executive Kenneth Frazier said he does not expect a wave of giant mergers in the drug industry despite a spate of recent activity, adding that Merck will seek out promising medicines rather than lower taxes in any future deals.
MAY May 6- Merck& Co Inc agrees to sell its consumer care business to Germany's Bayer AG for $14.2 billion. May 2- Pfizer Inc raises its offer for AstraZeneca Plc to 63 billion pounds, but the British company promptly rejects the proposal, which would create the world's biggest pharmaceuticals company.
Some of Tuesday's midday movers:
LONDON, May 6- Britain could use its public interest powers to intervene in U.S. drugmaker Pfizer's potential takeover of British pharmaceutical firm AstraZeneca, Business Secretary Vince Cable said on Tuesday.
European stocks closed lower on Tuesday, as continued violence in Ukraine and mixed earnings results made investors uneasy.
LONDON, May 6- AstraZeneca Plc laid out its defence against Pfizer Inc's $106- billion takeover approach on Tuesday by predicting its sales would rise by three quarters over the next decade, although only after a short-term drop. "These are benefits that should fully accrue to AstraZeneca's shareholders."
LONDON, May 6- Britain could use its powers to assess whether U.S. drugmaker Pfizer's potential takeover of British pharmaceutical firm AstraZeneca is in the public interest, Business Secretary Vince Cable said on Tuesday.
LONDON, May 6- British lawmakers on Tuesday summoned bosses of U.S. drugmaker Pfizer to explain a $106 billion takeover bid for pharmaceutical firm AstraZeneca which has raised fears over UK jobs, research and intellectual property.